Carson Wealth (CWM LLC)
GLUE icon

Carson Wealth (CWM LLC)’s Monte Rosa Therapeutics GLUE Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$488K Buy
29,687
+243
+0.8% +$4.65K ﹤0.01% 2034
2025
Q4 		$462K Buy
29,444
+3,536
+14% +$47.6K ﹤0.01% 1971
2025
Q3 		$192K Sell
25,908
-2,418
-9% -$12.8K ﹤0.01% 2482
2025
Q2 		$128K Buy
28,326
+24,620
+664% +$110K ﹤0.01% 2513
2025
Q1 		$17K Buy
3,706
+3,590
+3,095% +$22K ﹤0.01% 3798
2024
Q4 		$1K Buy
116
+60
+107% +$450 ﹤0.01% 4708
2024
Q3 		$0 Buy
56
+35
+167% +$177 ﹤0.01% 4941
2024
Q2 		$0 Buy
21
+19
+950% +$97 ﹤0.01% 4714
2024
Q1 		$0 Buy
+2
New +$12 ﹤0.01% 4479
2023
Q1 		– Sell
-34
Closed – – 4160
2022
Q4 		$0 Buy
+34
New +$283 ﹤0.01% 4076

Other funds holding GLUE

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Carson Wealth (CWM LLC)'s GLUE Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Monte Rosa Therapeutics (GLUE) stake by 0.83% in Q1 2026, buying an estimated $4.65K and bringing the position to 29,687 shares worth $488K. The position accounts for ﹤0.01% of the portfolio, ranked #2034.

Carson Wealth (CWM LLC) first reported a position in GLUE in Q4 2022 and has held it in 10 quarters since. 191 funds tracked by Wall St. Rank hold GLUE as of Q1 2026.

  • Carson Wealth (CWM LLC) held 29,687 shares of Monte Rosa Therapeutics worth $488K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 243 Monte Rosa Therapeutics shares in Q1 2026, an estimated $4.65K.
  • Monte Rosa Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2034 holding.
  • Carson Wealth (CWM LLC) first reported a position in Monte Rosa Therapeutics in Q4 2022 and has held it in 10 quarters since.
  • 191 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.